Stockscreener 앱 받기
56.24
2.85%
1.56
시간 외 거래:
56.39
0.15
+0.27%
전일 마감가:
$54.68
열려 있는:
$55.15
하루 거래량:
185.37K
Relative Volume:
0.63
시가총액:
$2.28B
수익:
$1.46B
순이익/손실:
$92.09M
주가수익비율:
24.93
EPS:
2.2555
순현금흐름:
$47.29M
1주 성능:
+3.59%
1개월 성능:
+1.30%
6개월 성능:
+36.67%
1년 성능:
+187.97%
1일 변동 폭
$55.07
$57.17
1주일 범위
$51.09
$57.17
52주 변동 폭
$18.89
$60.08
Phibro Animal Health Corp Stock (PAHC) Company Profile
명칭
Phibro Animal Health Corp
전화
201-329-7300
주소
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, ZTS, TEVA, HLN, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
56.24 | 2.22B | 1.46B | 92.09M | 47.29M | 2.2555 |
TAK
Takeda Pharmaceutical Co Adr
|
16.55 | 52.32B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
112.54 | 47.38B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.86 | 41.16B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.17 | 41.02B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
572.20 | 24.67B | 3.18B | 1.33B | 1.04B | 27.90 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Neutral |
| 2025-07-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-06-16 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | 개시 | JP Morgan | Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Underperform |
| 2022-12-21 | 개시 | ROTH Capital | Buy |
| 2022-07-25 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-01-10 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-11-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-08-05 | 재개 | Credit Suisse | Neutral |
| 2021-07-07 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2020-08-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-01-28 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-09-05 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | 재확인 | BofA/Merrill | Underperform |
| 2019-06-11 | 개시 | Barclays | Underweight |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-05-09 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2017-08-23 | 재개 | BofA/Merrill | Underperform |
| 2017-06-02 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | 개시 | Piper Jaffray | Overweight |
| 2016-11-11 | 다운그레이드 | Macquarie | Neutral → Underperform |
| 2016-11-10 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2016-04-11 | 재확인 | Guggenheim | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2016-01-15 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2015-09-30 | 개시 | Gabelli & Co | Buy |
| 2015-04-24 | 재확인 | Barclays | Overweight |
| 2015-04-21 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | 개시 | Barclays | Overweight |
모두보기
Phibro Animal Health Corp 주식(PAHC)의 최신 뉴스
Phibro Animal Health Corporation Launches Companywide Sustainable - The National Law Review
[8-K] PHIBRO ANIMAL HEALTH CORP Reports Material Event - Stock Titan
Phibro sets June 24 payout for $0.12-a-share quarterly dividend - Stock Titan
Phibro launches low-carbon feed ingredients to target Scope 3 emissions - Stock Titan
How Investors Are Reacting To Phibro Animal Health (PAHC) Expanding Its Revolving Credit Facility - Yahoo Finance
MSN Money - MSN
Phibro Animal Health Corp (PAHC) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Phibro Animal Health (NASDAQ:PAHC) CEO Sells $393,606.40 in Stock - MarketBeat
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 7,040 Shares of Stock - MarketBeat
Phibro Animal Health CEO Bendheim-linked entity sells $1.1m stock - Investing.com
CEO-associated BFI Co. trims Phibro (PAHC) stake under 10b5-1 plan - Stock Titan
Phibro Animal Health (NASDAQ: PAHC) raises revolver to $435M - Stock Titan
Phibro Animal Health Corp (NASDAQ: PAHC) — Vanguard holds 5.06% stake - Stock Titan
Precision Wealth Strategies LLC Purchases Shares of 41,973 Phibro Animal Health Corporation $PAHC - MarketBeat
Phibro investors get Q3 results May 6, webcast the next morning - Stock Titan
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results - ChartMill
Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials - The National Law Review
Phibro Animal Health (PAHC) to Release Earnings on Wednesday - MarketBeat
PAHC Stock Price, Quote & Chart | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
Phibro Animal Health Corp (PAHC) Shares Fall 3.3% -- GF Value Sa - GuruFocus
Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million - Yahoo Finance
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway - Yahoo Finance
Phibro Animal Health (PAHC) to Adapt to New Brazilian Antimicrob - GuruFocus
Assessing Phibro Animal Health (PAHC) Valuation After Powerful Share Price Momentum - Yahoo Finance
Brazil Bans Key Feed Antibiotics, Forcing Industry to Adapt - BriefGlance
Phibro Animal Health announces Brazil ban on growth‑promotion antimicrobials; 180‑day transition limits FY2026 impact - TradingView
Axecap Investments LLC Lowers Stake in Phibro Animal Health Corporation $PAHC - MarketBeat
Controlling holder of Phibro Animal Health (PAHC) reports 48.3% stake - Stock Titan
Phibro Animal Health CEO Bendheim sells $1.16m in PAHC stock - Investing.com Canada
Jack Bendheim Sells 7,040 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock - MarketBeat
BFI Co., LLC linked to PAHC (PAHC) sells 21,120 Class A shares - Stock Titan
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know - Yahoo Finance
Is It Too Late To Consider Phibro Animal Health (PAHC) After A 234.5% Rally? - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Upgraded at Citigroup - MarketBeat
Phibro Animal Health (PAHC) director sells $1.2m in shares By Investing.com - Investing.com India
Phibro Animal Health (PAHC) director sells $1.2m in shares - Investing.com
Pre-planned stock sales by Phibro (PAHC) CEO-linked entity - Stock Titan
Lobbying Update: $150,000 of PHIBRO ANIMAL HEALTH CORPORATION lobbying was just disclosed - Quiver Quantitative
PAHC Initiates Coverage by Citigroup -- Price Target Announced a - GuruFocus
Phibro Animal Health Corp. Opens with 5.07% Gain, Outperforming S&P 500 - Markets Mojo
Phibro Animal Health Corp. Hits New 52-Week High of $59.67 - Markets Mojo
Phibro Animal Health : PAHC - 24/7 Wall St.
Phibro Animal Health (NASDAQ:PAHC) Trading Down 4.5%Should You Sell? - MarketBeat
Is This the Right Time to Add PAHC Stock to Your Portfolio? - Yahoo Finance
Phibro director Joyce J. Lee to resign effective April 15, 2026 - TradingView
Board member Joyce Lee to leave Phibro Animal Health (NASDAQ: PAHC) - Stock Titan
Phibro Animal Health Corp (PAHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
2.13%
자본화:
|
볼륨(24시간):